Back to GOLDMAN SACHS GROUP INC GOLDMAN SACHS GROUP INC

TNGXTNGX
7 quarters

Position history for GOLDMAN SACHS GROUP INCGOLDMAN SACHS GROUP INC's holdings in Tango Therapeutics, Inc.

GOLDMAN SACHS GROUP INC holds 10M shares of TNGX (Tango Therapeutics, Inc.), worth $312M as of 2026-Q2. The position was increased (+96.6% shares). TNGX represents 0.0% of GOLDMAN SACHS GROUP INC's portfolio.

Current Value

$312M

Current Shares

10M

Total Value Change

+$310.5M

Total Shares Change

+9.5M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
10M
+96.6%
$312M0.0%$31.26
50
2026-Q1
Increased
5.1M
+2.7%
$106.2M0.0%$11.50
31
2025-Q4
Increased
4.9M
+227.4%
$43.8M0.0%$8.63
47
2025-Q3
Increased
1.5M
+1295.3%
$12.7M0.0%$8.44
45
2025-Q2
Decreased
108,179
-37.3%
$553,8770.0%$5.01
0
2025-Q1
Decreased
172,433
-64.6%
$236,2330.0%$1.47
0
2024-Q4
New
486,888
-
$1.5M0.0%$3.10
35

Other major holders of TNGX: RTW INVESTMENTS, LP, BlackRock, Inc., FMR LLC, FARALLON CAPITAL MANAGEMENT, L.L.C.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used